Dasatinib 70771-1901
Product NDC
70771-1901- Manufacturer
- Zydus Lifesciences Limited
- Dosage Form
- Tablet
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- March 3, 2025
- Listing Expires
- December 31, 2026
- Application
- ANDA218719
Need to source Dasatinib? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Dasatinib | 20 mg/1 |
Drug Class
Cytochrome P450 3A4 Inhibitors [MoA]Kinase Inhibitor [EPC]Protein Kinase Inhibitors [MoA]
Packaging Options(1)
60 TABLET in 1 BOTTLE (70771-1901-6)